Overview

Genefiletics, founded in the year 2019, is a biotech company pioneering breakthrough discoveries in microbial science to develop pipeline of precision diagnostic, therapeutics, consumer health innovations & environmental solutions in order to promote better health & longevity & improve biodiversity of soil & aquatic life tied to human health. The company offers Industry' first human microbiome therapeutics platform that sequences & analyse gut, oral & vaginal microbiome to measure biology + chemistry of an individual at a molecular level & then apply machine learning to determine molecular signatures predictive of chronic diseases & provide disease modifying therapeutic interventions. The company is led by a team of researchers, inventors, industry experts & passionate & curious entrepreneurs with a combined leadership & executive experience of 30 + years who are on a journey to impact human & environmental health. The company has been awarded as 1)Microbiome Therapeutics as a service platform, 2023 by AWS & MINFY in association with CNBC 2)Chronic Illness Prevention R&D Biotech Company- Asia,2022 by Global Health Pharma 3)Specialist Biotech Company of the year, CorporateLiveWire, Global Awards, 2022/23 4) Microbiome Therapeutics as a service platform, 2023 by Global Health & Pharma 5) Chronic Illness Prevention R&D Biotech Company of the Year 2023 - Asia by AI Global Media